Expanded Access to SUVN-G3031 (Samelisant) for the Treatment of Subjects With Narcolepsy

A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy

NCT01681121 ·Status: COMPLETED ·Phase: PHASE2

Treating Insomnia and Improving Metabolic Health in Midlife Women With Insomnia

NCT05593653 ·Status: COMPLETED ·Phase: PHASE4

A Study of LY3154207 on Sleep in Healthy Male Participants

NCT02603861 ·Status: COMPLETED ·Phase: PHASE1

This is a Study to Determine the Effect of Multiple Doses of an Investigational Drug, Taken by Mouth, in People With Narcolepsy-cataplexy. Accepting Both Males and Females Ages of 18 Years to 55 Years. This Study Will be Conducted in the US and Will Require Approximately 13 Weeks Participation.

NCT05015673 ·Status: COMPLETED ·Phase: PHASE1

Study of MK-6552 in Participants With Narcolepsy Type 1 (MK-6552-004)

NCT06179407 ·Status: TERMINATED ·Phase: PHASE1

A Study of the Safety and Effectiveness of ADX-N05 in the Treatment of Excessive Daytime Sleepiness

NCT01485770 ·Status: COMPLETED ·Phase: PHASE2

Efficacy Study of EVT 201 in the Treatment of Elderly Patients With Daytime Sleepiness

NCT00401284 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Tolerance of Solriamfetol in Patients Affected with Idiopathic Hypersomnia.

NCT06590662 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Modafinil Versus Amphetamines for the Treatment of Narcolepsy Type 2 and Idiopathic Hypersomnia

NCT03772314 ·Status: COMPLETED ·Phase: PHASE2

Suvorexant on Sleep Disturbance in Patients With Chronic Insomnia and Suboptimally Controlled Type 2 Diabetes

NCT03818581 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate the Safety and Efficacy of TS-091 in Patients with Narcolepsy

NCT03267303 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy Study of Suvorexant in Participants With Primary Insomnia - Study A (MK-4305-028)

NCT01097616 ·Status: COMPLETED ·Phase: PHASE3

Solriamfetol and CBT-I in Patients With Insomnia Disorder

NCT05838430 ·Status: COMPLETED ·Phase: PHASE4

Efficacy of Suvorexant in Patients With Effectively Treated Restless Legs Syndrome and Persistent Chronic Insomnia

NCT04706091 ·Status: COMPLETED ·Phase: PHASE4

A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia

NCT06752668 ·Status: RECRUITING ·Phase: PHASE2

A Multicenter Study of the Efficacy and Safety of JZP-258 in the Treatment of Idiopathic Hypersomnia (IH) With an Open-label Safety Extension

NCT03533114 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy Study of Suvorexant in Participants With Primary Insomnia - Study B (MK-4305-029)

NCT01097629 ·Status: COMPLETED ·Phase: PHASE3

Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep

NCT03575104 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-48816274

NCT02852395 ·Status: COMPLETED ·Phase: PHASE1

Solriamfetol's Effect on Cognitive Health in Apnea Participants During a Randomized Placebo-controlled Study

NCT04789174 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 2

NCT06555783 ·Status: COMPLETED ·Phase: PHASE2

Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects With Insomnia Disorder

NCT03545191 ·Status: COMPLETED ·Phase: PHASE3

Impact of Suvorexant on Sympathetic Nerve Activity and Baroreflex Function in Chronic Insomnia

NCT03768713 ·Status: UNKNOWN ·Phase: PHASE4

A Study to Assess the Pharmacodynamic Effects of SAGE-217 in Healthy Adults Using an Insomnia Model

NCT03284931 ·Status: COMPLETED ·Phase: PHASE1

Long-term Study of Lemborexant in Insomnia Disorder (SUNRISE 2)

NCT02952820 ·Status: COMPLETED ·Phase: PHASE3